Latest news with #AchinGupta
&w=3840&q=100)
Business Standard
21-07-2025
- Business
- Business Standard
Cipla buys 20% stake in iCaltech to broaden respiratory device portfolio
Cipla on Monday announced that it has entered into definitive agreements to acquire a 20 per cent stake in Bengaluru-based iCaltech Innovations, through an investment of approximately ₹5 crore in optionally convertible preference shares and one equity share. The transaction is expected to be completed within a month, subject to customary closing conditions. The investment aligns with Cipla's strategy to strengthen its presence in the respiratory care space, particularly in the diagnostics segment. iCaltech, an ISO 13485 certified medical device company, is engaged in the design, development, manufacturing, and commercialisation of diagnostic products, with a core focus on respiratory applications. Achin Gupta, Global COO, Cipla, said, 'Our decision to invest in iCaltech reflects Cipla's commitment to advancing respiratory diagnostics. As lung leaders with the aim to reduce the existing gap in the current ecosystem, our strategic funding will enable iCaltech to further expand and develop innovative devices.' Cipla said the deal would enable it to partner with iCaltech in developing integrated healthcare solutions by leveraging synergies between pharmaceuticals and medical device technologies. Under the terms, iCaltech will continue to operate independently, while Cipla will hold 20 per cent voting rights post-investment. iCaltech recorded a revenue of ₹6.7 crore in FY25, up from ₹4.19 crore in FY24 and ₹1.28 crore in FY23. The acquisition is part of Cipla's broader focus on expanding its devices, diagnostics, and digital offerings, especially in its core respiratory portfolio.
News18
21-07-2025
- Business
- News18
Cipla signs pact to invest in iCaltech Innovations
Agency: PTI New Delhi, Jul 21 (PTI) Drug firm Cipla Ltd on Monday said it has inked definitive agreements to invest in iCaltech Innovations. The Mumbai-based company, however, did not share financial details. iCaltech is engaged in the design, development, and commercialisation of diagnostic medical equipment and apparatus, with a core focus on respiratory care. Achin Gupta, Global COO, Cipla Limited, said, 'As lung leaders, our decision to invest in iCaltech reflects Cipla's commitment to advancing respiratory diagnostics." To reduce the existing gap in the current ecosystem, the strategic funding will enable iCaltech to further expand and develop innovative devices, he added. PTI MSS MR MR Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Associated Press
27-05-2025
- Business
- Associated Press
AG Organica Pioneers Innovation in Natural Skincare Through Advanced R&D and Custom Formulation Excellence
AG Organica Pioneers Innovation in Natural Skincare Through Advanced R&D and Custom Formulation Excellence GURUGRAM, HARYANA, INDIA, May 27, 2025 / / -- In a significant stride for the personal care industry, AG Organica Private Limited is leading innovation in natural skincare manufacturing by integrating advanced research and development practices with a deep understanding of evolving dermatological needs. This move highlights a broader shift in the industry toward science-backed, clean-label skincare solutions that prioritize both efficacy and sustainability. Through its dedicated R&D division, AG Organica is developing high-performance skincare formulations that align with modern consumer expectations for transparency, ingredient integrity, and proven results. The company collaborates closely with dermatologists, D2C beauty brands, spas, and wellness-focused enterprises to develop customized products using cutting-edge active ingredients—such as Niacinamide, Retinol, Hyaluronic Acid, and Vitamin C—infused with botanical oils, herbs, and natural extracts. 'Modern skincare is at the intersection of science and sustainability,' said Achin Gupta, Director of AG Organica. 'Our in-house chemists and formulation experts are continuously exploring new ways to create natural, effective skincare that reflects global trends while maintaining product safety and integrity.' AG Organica's work in formulation innovation is supported by rigorous quality standards, including FDA compliance, batch stability testing, and third-party validation. The company's infrastructure supports both small-batch prototyping and large-scale production, enabling inclusive access to next-generation skincare manufacturing for brands of all sizes. As concerns over synthetic additives, greenwashing, and environmental impact grow, AG Organica's evidence-based approach to plant-powered skincare innovation signals a promising shift in how the industry can serve both consumers and the planet. About AG Organica Private Limited AG Organica is a pioneering Indian manufacturer specializing in essential oils, botanical cosmetics, and clean-label personal care. The company partners with global brands, healthcare professionals, and wellness experts to develop next-generation formulations rooted in natural science and ethical sourcing. ARPIT GUPTA A.G Organica Private Limited +91 99118 39839 email us here Visit us on social media: LinkedIn Bluesky Instagram Facebook YouTube X Other Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Time of India
26-05-2025
- Health
- Time of India
Cipla's new film reinforces its commitment to reach every patient
HighlightsCipla has launched the second film of its national brand campaign, '1935 Se Desh Ki Sehat Ke Saath,' which commemorates nine decades of promoting access to life-saving treatments and healthcare equity. The latest film, inspired by a real-life incident during devastating landslides in northern India, showcases Cipla's commitment to delivering essential healthcare despite challenging conditions. Filmmaker Shoojit Sircar and Dentsu Creative India collaborated with Cipla to create a narrative that emphasizes the importance of accessible healthcare and the resilience of the human spirit. Cipla has unveiled the second film under its national brand campaign , '1935 Se Desh Ki Sehat Ke Saath,' celebrating nine decades of championing access to life-saving treatments and healthcare equity for all. While the first film paid tribute to the healthcare community and Cipla's enduring role in empowering them, the latest chapter builds on this legacy by bringing to life the company's deep rooted commitment to enabling access across the country. This film's narrative is inspired by a real-life story that unfolded during a natural disaster, capturing Cipla's unwavering resolve to put patients first, no matter the challenge. At the heart of the film lies a moving incident that occurred during a time of devastating landslides in a remote northern region of India. Amid harsh conditions and shattered connectivity, Cipla's team braved the odds to swiftly deliver life-saving treatments to those in urgent need. Through this story, the film echoes a powerful message, 'When the mission is the nation, no terrain is too tough.' To bring this second chapter to life, Cipla collaborated with filmmaker Shoojit Sircar and Dentsu Creative India . Achin Gupta, global chief operating officer, Cipla, said, 'It pays tribute to 90 years of people-first healthcare and reaffirms our ongoing commitment to improving lives through science, empathy, and communication.' Shoojit Sircar, director, said, 'We wanted to show a real moment where care transcends the challenges of a crisis. Stories like these inspire us and highlight the importance of accessible healthcare. At the heart of our storytelling were the human spirit and Cipla's purpose.' Watch the videos here:
